These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27010138)

  • 1. Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer.
    Zhang X; Zhang H
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):837-41. PubMed ID: 27010138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low miR-498 expression levels are associated with poor prognosis in ovarian cancer.
    Cong J; Liu R; Wang X; Wang J; Wang H; Hou J
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4762-5. PubMed ID: 26744867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
    Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
    Gong L; Wang C; Gao Y; Wang J
    Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
    Leskelä S; Leandro-García LJ; Mendiola M; Barriuso J; Inglada-Pérez L; Muñoz I; Martínez-Delgado B; Redondo A; de Santiago J; Robledo M; Hardisson D; Rodríguez-Antona C
    Endocr Relat Cancer; 2011 Feb; 18(1):85-95. PubMed ID: 21051560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
    Ma YB; Li GX; Hu JX; Liu X; Shi BM
    Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
    Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
    Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.
    Chan JK; Kiet TK; Blansit K; Ramasubbaiah R; Hilton JF; Kapp DS; Matei D
    Gynecol Oncol; 2014 Jun; 133(3):568-74. PubMed ID: 24680769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-335 represents an independent prognostic marker in epithelial ovarian cancer.
    Cao J; Cai J; Huang D; Han Q; Chen Y; Yang Q; Yang C; Kuang Y; Li D; Wang Z
    Am J Clin Pathol; 2014 Mar; 141(3):437-42. PubMed ID: 24515774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
    Shi C; Zhang Z
    Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the miR-200 family in ovarian cancer: a meta-analysis.
    Shi C; Zhang Z
    Acta Obstet Gynecol Scand; 2016 May; 95(5):505-12. PubMed ID: 26910180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
    Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
    Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
    Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
    Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.